Age‐ and risk factor–based serologic screening for Hepatitis C virus among an Urban, high‐risk population

2020 ◽  
Vol 27 (12) ◽  
pp. 1369-1387
Author(s):  
Rositsa B. Dimova ◽  
Eric Rude ◽  
Andrew H. Talal
Keyword(s):  
Risk Factor ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
High Risk ◽  
High Risk Population ◽  
Risk Population ◽  
Serologic Screening

Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population

1995 ◽  
Vol 14 (3) ◽  
pp. 195-198 ◽  
Author(s):  
SUSANNA PACCAGNINI ◽  
NICOLA PRINCIPI ◽  
EMILIA MASSIRONI ◽  
ELISABETTA TANZI ◽  
LUISA ROMANO ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
High Risk ◽  
Virus Infection ◽  
Perinatal Transmission ◽  
High Risk Population ◽  
Hepatitis C Virus Infection ◽  
Risk Population

scholarly journals P-91 PREVALENCE OF HEPATITIS C VIRUS INFECTION DETECTED BY RAPID TEST IN A HIGH-RISK POPULATION

2021 ◽  
Vol 24 ◽  
pp. 100454
Author(s):  
Pedro Montes Teves ◽  
Briny Rodriguez Vargas ◽  
Jaime Fustamante Flores ◽  
Eduardo Monge Salgado
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
High Risk ◽  
Virus Infection ◽  
Rapid Test ◽  
High Risk Population ◽  
Hepatitis C Virus Infection ◽  
Risk Population

scholarly journals Complex patterns of Hepatitis-C virus longitudinal clustering in a high-risk population

2018 ◽  
Vol 58 ◽  
pp. 77-82 ◽  
Author(s):  
Rebecca Rose ◽  
Susanna L. Lamers ◽  
Guido Massaccesi ◽  
William Osburn ◽  
Stuart C. Ray ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
High Risk ◽  
High Risk Population ◽  
Risk Population ◽  
Complex Patterns

scholarly journals Endothelial dysfunction: The contribution of diabetes mellitus to the risk factor burden in a high risk population

2013 ◽  
Vol 06 (06) ◽  
pp. 593-597 ◽  
Author(s):  
Muluemebet Ketete ◽  
Rabia Cherqaoui ◽  
Abid R. Maqbool ◽  
John Kwagyan ◽  
Shichen Xu ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Risk Factor ◽  
High Risk ◽  
Endothelial Dysfunction ◽  
High Risk Population ◽  
Risk Population ◽  
Risk Factor Burden

Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study

2019 ◽  
Vol 70 (10) ◽  
pp. 2199-2205 ◽  
Author(s):  
Bernd Schulte ◽  
Christiane Sybille Schmidt ◽  
Lisa Strada ◽  
Moritz Rosenkranz ◽  
Ingo Schäfer ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
High Risk ◽  
Incidence Rates ◽  
Hcv Rna ◽  
High Risk Population ◽  
Substitution Treatment ◽  
Opioid Substitution Treatment ◽  
Hcv Antibody ◽  
Opioid Substitution

Abstract Background Hepatitis C virus (HCV) infection is highly prevalent among people who inject drugs (PWID). Accurate data on HCV prevalence and incidence rates among patients receiving opioid substitution treatment (OST) are needed to estimate the current and future burden of HCV infections in this high-risk population. Methods Baseline data from routine care were collected between October 2014 and June 2016 from randomly selected OST facilities in Germany. The primary outcome measure was the HCV status (antibody and RNA prevalence). Patients who were HCV antibody–negative at baseline were followed up after 12 months to calculate the HCV incidence rate. Results Sixty-three facilities from 14 German Federal States provided clinical data for a total of 2466 OST patients. HCV antibody and HCV RNA prevalence were 58.8% (95% confidence interval [CI], 56.8%–60.8%) and 27.3% (95% CI, 25.5%–29.2%), respectively. At baseline, a total of 528 patients (21.4%) had previously undergone antiviral treatment. Moreover, lower HCV RNA prevalence was associated with female gender, employment, younger age, and shorter duration of OST and opioid dependence. The HCV incidence rate was 2.5 cases per 100 person-years. Conclusions The low HCV RNA prevalence and HCV incidence rates confirm that OST in Germany is an effective setting both for treating chronic HCV infections and for preventing new infections among PWID. Scaling up the provision of OST, HCV testing, and HCV treatment among OST patients are important public health strategies for reducing HCV infections in this high-risk population.

Hepatitis C Virus Screening Among Adolescents Attending a Drug Rehabilitation Center

2019 ◽  
Vol 9 (4) ◽  
pp. 437-441 ◽  
Author(s):  
Neil Dominic Fernandes ◽  
Swagata Banik ◽  
Nazha Abughali ◽  
Bonisha Sthapit ◽  
Neelab Abdullah ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
High Risk ◽  
Hcv Infection ◽  
Health Concern ◽  
High Risk Population ◽  
Drug Rehabilitation ◽  
Rehabilitation Center ◽  
Hcv Screening ◽  
Hcv Testing

Abstract Background Hepatitis C virus (HCV) infection has a strong association with intravenous drug use (IVDU). IVDU is a growing public health concern, even in the adolescent population. To our knowledge, there are no published HCV screening studies targeting high-risk adolescents who attend drug rehabilitation centers. This study was designed to determine the seroprevalence of HCV infection utilizing point-of-care (POC) testing at an adolescent drug rehabilitation center and gain a preliminary understanding of the acceptance rate for HCV screening in this high-risk population. Methods This single-center, observational study was conducted at a major drug rehabilitation center in northeast Ohio from July 2016 to June 2017. The consented adolescents who presented at the center were recruited to participate in HCV screening. The participants were administered a survey to assess their demographics and risk behavior profile followed by HCV testing utilizing a POC test. Results During the study period, 150 adolescents were admitted to the drug rehabilitation center, of whom 100 were approached and 85 agreed to participate. Forty percent of the participants (34/85) were females, and 78% (66/85) were white. HCV prevalence among participants was 5% (4/85), all of whom were females. History of heroin use was reported by 15% (13/85) and it was associated with HCV seropositivity; 100% (4/4) of all HCV-positive individuals reported the use of heroin vs only 11% (9/81) of HCV-negative individuals (P = .0004). Conclusions Our study showed a high prevalence of HCV among adolescents attending a drug rehabilitation center with high acceptance of POC HCV testing.

Sign in / Sign up

Export Citation Format

Share Document